Cutaneous T-Cell Lymphoma (CTCL) Active Not Recruiting Phase 2 Trials for Romidepsin (DB06176)

Also known as: Lymphoma, Cutaneous T-Cell / Cutaneous T-Cell Lymphomas / Cutaneous T-Cell Lymphoma / Cutaneous lymphoma / Lymphoma, T-Cell, Cutaneous

IndicationStatusPhase
DBCOND0071861 (Cutaneous T-Cell Lymphoma (CTCL))Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00007345Depsipeptide to Treat Patients With Cutaneous T-Cell Lymphoma and Peripheral T-Cell LymphomaTreatment